NEOSKILAB Solution for injection
NEOSKILAB Solution for injection
Authorised
- NEOSTIGMINE METHYLSULFATE
Product identification
Medicine name:
NEOSKILAB Solution for injection
NEOSKILAB 1,5 mg/ml solução injetável para bovinos, ovinos, caprinos e equinos
Active substance:
- NEOSTIGMINE METHYLSULFATE
Target species:
-
Cattle
-
Sheep
-
Goat
-
Horse
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
NEOSTIGMINE METHYLSULFATE1.50milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
-
Meat and offalno withdrawal periodwithdrawal period is 0 days
-
Milkno withdrawal periodwithdrawal period is 0 days
-
- Sheep
-
Meat and offalno withdrawal periodwithdrawal period is 0 days
-
Milkno withdrawal periodwithdrawal period is 0 days
-
- Goat
-
Meat and offalno withdrawal periodwithdrawal period is 0 days
-
Milkno withdrawal periodwithdrawal period is 0 days
-
- Horse
-
Meat and offalno withdrawal periodwithdrawal period is 0 days
-
Milkno withdrawal periodwithdrawal period is 0 days
-
-
Subcutaneous use
- Cattle
-
Meat and offalno withdrawal periodwithdrawal period is 0 days
-
Milkno withdrawal periodwithdrawal period is 0 days
-
- Sheep
-
Meat and offalno withdrawal periodwithdrawal period is 0 days
-
Milkno withdrawal periodwithdrawal period is 0 days
-
- Goat
-
Meat and offalno withdrawal periodwithdrawal period is 0 days
-
Milkno withdrawal periodwithdrawal period is 0 days
-
- Horse
-
Meat and offalno withdrawal periodwithdrawal period is 0 days
-
Milkno withdrawal periodwithdrawal period is 0 days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN07AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- box containing 1 vial of 25 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Labiana Life Sciences S.A.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 1425/01/21DFVPT
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0389/001
Concerned member states:
-
Belgium
-
Croatia
-
Cyprus
-
Estonia
-
France
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Portugal
-
Romania
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 26/04/2022
Summary of Product Characteristics
English (PDF)
Download Published on: 12/04/2023
How useful was this page?: